IMR Press / FBL / Volume 24 / Issue 2 / DOI: 10.2741/4722

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

The effects of silver nanoparticles on RAW 264.7. Macrophages and human whole blood cell cultures
Show Less
1 Department of Medical Bioscience, University of the Western Cape, Cape Town, 7535, South Africa
2 Natural Resources and the Environment (NRE), Council for Scientific and Industrial Research (CSIR), Stellenbosch, South Africa
*Correspondence: (Edmund J Pool)
Front. Biosci. (Landmark Ed) 2019, 24(2), 347–365;
Published: 1 January 2019

Silver nanoparticles (AgNPs) are commonly found in consumer products due to their antimicrobial properties. This study evaluated the effects of AgNPs on the murine macrophage cell line RAW 264.7 and human whole blood cell cultures (WBCs). Effects of AgNPs on RAW cells were assessed in the presence or absence of lipopolysaccharide (LPS). Effects of AgNPs on WBCs were monitored under basal conditions and in the presence of either LPS or phytohaemmagglutinin (PHA). AgNPs were cytotoxic to WBCs at 250 μg/ml. Under basal conditions, RAW cells ≥ 62.5. μg/ml and WBCs > 25 μg/ml AgNPs induced biomarkers associated with inflammation. Under LPS stimulated conditions, 250 μg/ml AgNP inhibited biomarkers associated with inflammation for both cultures. Under basal conditions, and in the presence of 250 μg/ml AgNP, WBCs produced acquired immune system cytokines IL-10 and IFNγ. IL-10 synthesis by WBCs was partially inhibited by 250 μg/ml AgNP in the presence of PHA. Proteome profiles of RAW cell supernatants show that AgNPs modulate biomarkers associated with inflammation. WBCs proteome analysis shows modulation of biomarkers associated with anti-inflammatory effects.

Silver nanoparticles
Cell viability
Inflammatory biomarkers
Proteome analysis
Cytokines and chemokines
Figure 1
Back to top